[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Smith et al., 2014 - Google Patents

Recurrent postmenopausal bleeding: a prospective cohort study

Smith et al., 2014

Document ID
15787720593789657433
Author
Smith P
O'Connor S
Gupta J
Clark T
Publication year
Publication venue
Journal of minimally invasive gynecology

External Links

Snippet

Abstract Study Objective To estimate the prevalence of genital tract diseases in women with initial and recurrent postmenopausal bleeding (PMB) to help inform diagnostic pathways. Design Prospective cohort study (Canadian Task Force classification: II-2). Setting Large …
Continue reading at www.sciencedirect.com (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/574—Immunoassay; Biospecific binding assay for cancer
    • G01N33/57407—Specifically defined cancers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
    • A61B8/52—Devices using data or image processing specially adapted for diagnosis using ultrasonic, sonic or infrasonic waves
    • A61B8/5215—Devices using data or image processing specially adapted for diagnosis using ultrasonic, sonic or infrasonic waves involving processing of medical diagnostic data
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/43—Detecting, measuring or recording for evaluating the reproductive systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
    • A61B8/48—Diagnostic techniques

Similar Documents

Publication Publication Date Title
Smith et al. Recurrent postmenopausal bleeding: a prospective cohort study
Gull et al. Can ultrasound replace dilation and curettage? A longitudinal evaluation of postmenopausal bleeding and transvaginal sonographic measurement of the endometrium as predictors of endometrial cancer
Van Hanegem et al. Diagnostic evaluation of the endometrium in postmenopausal bleeding: an evidence-based approach
Svirsky et al. Can we rely on blind endometrial biopsy for detection of focal intrauterine pathology?
Fung et al. Prospective longitudinal study of ultrasound screening for endometrial abnormalities in women with breast cancer receiving tamoxifen
Litta et al. Role of hysteroscopy with endometrial biopsy to rule out endometrial cancer in postmenopausal women with abnormal uterine bleeding
Vitner et al. A comparison between ultrasonography and hysteroscopy in the diagnosis of uterine pathology
Breitkopf et al. Detection of benign endometrial masses by endometrial stripe measurement in premenopausal women
Yasa et al. Evaluation of the diagnostic role of transvaginal ultrasound measurements of endometrial thickness to detect endometrial malignancy in asymptomatic postmenopausal women
Gage et al. Detection of cervical cancer and its precursors by endocervical curettage in 13,115 colposcopically guided biopsy examinations
Kil et al. Usefulness of CA125 in the differential diagnosis of uterine adenomyosis and myoma
Opolskiene et al. Prediction of endometrial malignancy in women with postmenopausal bleeding and sonographic endometrial thickness≥ 4.5 mm
Timmermans et al. Diagnostic accuracy of endometrial thickness to exclude polyps in women with postmenopausal bleeding
Patel et al. Endometrial thickness as measured by transvaginal ultrasound and the corresponding histopathologic diagnosis in women with postmenopausal bleeding
Liang et al. Evaluation of 3D-CPA, HR-HPV, and TCT joint detection on cervical disease screening
Macdonald et al. Influence of high risk HPV genotype on colposcopic performance: A large prospective study demonstrates improved detection of disease with ZedScan I, particularly in non-HPV 16 patients
Kanmaz et al. Importance of transvaginal ultrasonography before endometrial sampling in asymptomatic postmenopausal patients
Firdous et al. Role of hysteroscopy and histopathology in evaluating patients with abnormal uterine bleeding
Nguyen Evaluating clinical features in intracavitary uterine pathologies among Vietnamese women presenting with peri-and postmenopausal bleeding: a bicentric observational descriptive analysis
Dermawan et al. Thickened endometrium in postmenopausal women with an initial biopsy of limited, benign, surface endometrium: clinical outcome and subsequent pathologic diagnosis
Nguyen et al. Assessment of paraclinical characteristics in peri-and postmenopausal bleeding women: is there a correlation between hemoglobin levels and ultrasonic indices?
Tsuda et al. Transvaginal ultrasonography of the endometrium in postmenopausal Japanese women
Veena et al. Addition of power Doppler to grey scale transvaginal ultrasonography for improving the prediction of endometrial pathology in perimenopausal women with abnormal uterine bleeding
Tidy et al. Increased detection of high grade CIN, when using electrical impedance spectroscopy as an adjunct to routine colposcopy, is maintained when used across international boundaries: Prospective data from nine European countries
Li et al. The incidence and predictors of gynecologic malignancies among postmenopausal patients with endometrial fluid collection